Guardian Investment Management Amgen Inc Transaction History

Guardian Investment Management

$125 Million
Q3 2024

A detailed history of Guardian Investment Management transactions in Amgen Inc stock. As of the latest transaction made, Guardian Investment Management holds 14,179 shares of AMGN stock, worth $4.18 Million. This represents 3.67% of its overall portfolio holdings.

Number of Shares

14,179

Previous 17,828 20.47%

Holding current value

$4.18 Million

Previous $5.57 Million 17.99%

% of portfolio

3.67%

Previous 3.83%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$309.38 - $337.38 $1.13 Million - $1.23 Million	-3,649 Reduced 20.47%	14,179 $4.57 Million
Q2 2024 Jul 23, 2024	BUY	$262.75 - $319.31 $787,987 - $957,610	2,999 Added 20.22%	17,828 $5.57 Million
Q1 2024 Apr 26, 2024	SELL	$268.87 - $324.56 $66,948 - $80,815	-249 Reduced 1.65%	14,829 $4.22 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $268,229 - $302,594	-1,049 Reduced 6.5%	15,078 $4.34 Million
Q3 2023 Oct 13, 2023	BUY	$218.65 - $271.46 $35,639 - $44,247	163 Added 1.02%	16,127 $4.33 Million
Q2 2023 Jul 14, 2023	SELL	$214.27 - $253.37 $253,481 - $299,736	-1,183 Reduced 6.9%	15,964 $3.54 Million
Q1 2023 May 05, 2023	BUY	$225.79 - $275.2 $256,271 - $312,352	1,135 Added 7.09%	17,147 $4.15 Million
Q4 2022 Jan 12, 2023	SELL	$229.03 - $291.01 $5,954 - $7,566	-26 Reduced 0.16%	16,012 $0
Q3 2022 Oct 12, 2022	BUY	$224.46 - $253.15 $22,446 - $25,315	100 Added 0.63%	16,038 $3.61 Million
Q2 2022 Jul 19, 2022	BUY	$230.71 - $256.74 $80,979 - $90,115	351 Added 2.25%	15,938 $3.88 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $10,744 - $11,885	49 Added 0.32%	15,587 $3.77 Million
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $196,891 - $225,324	990 Added 6.81%	15,538 $3.5 Million
Q3 2021 Oct 13, 2021	SELL	$212.27 - $248.7 $530,462 - $621,501	-2,499 Reduced 14.66%	14,548 $3.09 Million
Q2 2021 Jul 14, 2021	SELL	$233.58 - $259.14 $23,358 - $25,914	-100 Reduced 0.58%	17,047 $4.16 Million
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $33,508 - $39,048	-151 Reduced 0.87%	17,147 $4.27 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $54,673 - $60,801	-233 Reduced 1.33%	17,298 $4.4 Million
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $112,012 - $143,974	-592 Reduced 3.27%	17,531 $4.23 Million
Q3 2019 Oct 24, 2019	BUY	$174.11 - $208.62 $1,741 - $2,086	10 Added 0.06%	18,123 $3.51 Million
Q2 2019 Aug 16, 2019	BUY	$166.7 - $195.41 $101,687 - $119,200	610 Added 3.49%	18,113 $3.34 Million
Q1 2019 Apr 22, 2019	SELL	$180.87 - $203.88 $438,067 - $493,797	-2,422 Reduced 12.16%	17,503 $3.33 Million
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $103,472 - $120,785	580 Added 3.0%	19,925 $5.16 Million
Q3 2018 Oct 19, 2018	SELL	$185.29 - $208.89 $136,002 - $153,325	-734 Reduced 3.66%	19,345 $4.01 Million
Q2 2018 Jul 13, 2018	BUY	$166.05 - $186.51 $540,990 - $607,649	3,258 Added 19.37%	20,079 $3.71 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $99,116 - $115,830	585 Added 3.6%	16,821 $2.87 Million
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $2.72 Million - $3.1 Million	16,236	16,236 $3.03 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Investment Management with notifications on news.

Account

Guardian Investment Management Amgen Inc Transaction History